'en:mesangial matrix expansion'
(id=6796467 ; fe=en:mesangial matrix expansion ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=15913 creation date=2017-06-25 touchdate=2025-07-25 19:50:11.000) ≈ 438 relations sortantes
- en:mesangial matrix expansion --
r_associated #0: 43 / 1 ->
en:duplicated calyx
n1=en:mesangial matrix expansion | n2=en:duplicated calyx | rel=r_associated | relid=0 | w=43
- en:mesangial matrix expansion --
r_associated #0: 43 / 1 ->
en:renal stone
n1=en:mesangial matrix expansion | n2=en:renal stone | rel=r_associated | relid=0 | w=43
- en:mesangial matrix expansion --
r_associated #0: 42 / 0.977 ->
en:glomerular c3 deposits, subendothelial and mesangial
n1=en:mesangial matrix expansion | n2=en:glomerular c3 deposits, subendothelial and mesangial | rel=r_associated | relid=0 | w=42
- en:mesangial matrix expansion --
r_associated #0: 42 / 0.977 ->
en:hematuria, gross (in some patients)
n1=en:mesangial matrix expansion | n2=en:hematuria, gross (in some patients) | rel=r_associated | relid=0 | w=42
- en:mesangial matrix expansion --
r_associated #0: 41 / 0.953 ->
en:inability to concentrate urine
n1=en:mesangial matrix expansion | n2=en:inability to concentrate urine | rel=r_associated | relid=0 | w=41
- en:mesangial matrix expansion --
r_associated #0: 41 / 0.953 ->
en:loss of podocyte foot processes
n1=en:mesangial matrix expansion | n2=en:loss of podocyte foot processes | rel=r_associated | relid=0 | w=41
- en:mesangial matrix expansion --
r_associated #0: 41 / 0.953 ->
en:mesangial cell proliferation
n1=en:mesangial matrix expansion | n2=en:mesangial cell proliferation | rel=r_associated | relid=0 | w=41
- en:mesangial matrix expansion --
r_associated #0: 41 / 0.953 ->
en:renal agenesis/hypoplasia (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal agenesis/hypoplasia (in some patients) | rel=r_associated | relid=0 | w=41
- en:mesangial matrix expansion --
r_associated #0: 41 / 0.953 ->
en:renal cortical microcysts
n1=en:mesangial matrix expansion | n2=en:renal cortical microcysts | rel=r_associated | relid=0 | w=41
- en:mesangial matrix expansion --
r_associated #0: 40 / 0.93 ->
en:renal tubular acidosis
n1=en:mesangial matrix expansion | n2=en:renal tubular acidosis | rel=r_associated | relid=0 | w=40
- en:mesangial matrix expansion --
r_associated #0: 39 / 0.907 ->
en:chronic kidney disease, stage 5
n1=en:mesangial matrix expansion | n2=en:chronic kidney disease, stage 5 | rel=r_associated | relid=0 | w=39
- en:mesangial matrix expansion --
r_associated #0: 39 / 0.907 ->
en:dysplastic kidney (1 patient)
n1=en:mesangial matrix expansion | n2=en:dysplastic kidney (1 patient) | rel=r_associated | relid=0 | w=39
- en:mesangial matrix expansion --
r_associated #0: 39 / 0.907 ->
en:glomerulonephritis, autoimmune
n1=en:mesangial matrix expansion | n2=en:glomerulonephritis, autoimmune | rel=r_associated | relid=0 | w=39
- en:mesangial matrix expansion --
r_associated #0: 38 / 0.884 ->
en:basement membrane thickening
n1=en:mesangial matrix expansion | n2=en:basement membrane thickening | rel=r_associated | relid=0 | w=38
- en:mesangial matrix expansion --
r_associated #0: 38 / 0.884 ->
en:deficient nephron differentiation
n1=en:mesangial matrix expansion | n2=en:deficient nephron differentiation | rel=r_associated | relid=0 | w=38
- en:mesangial matrix expansion --
r_associated #0: 38 / 0.884 ->
en:duplex kidney
n1=en:mesangial matrix expansion | n2=en:duplex kidney | rel=r_associated | relid=0 | w=38
- en:mesangial matrix expansion --
r_associated #0: 38 / 0.884 ->
en:left kidney
n1=en:mesangial matrix expansion | n2=en:left kidney | rel=r_associated | relid=0 | w=38
- en:mesangial matrix expansion --
r_associated #0: 38 / 0.884 ->
en:membranous glomerulonephritis
n1=en:mesangial matrix expansion | n2=en:membranous glomerulonephritis | rel=r_associated | relid=0 | w=38
- en:mesangial matrix expansion --
r_associated #0: 37 / 0.86 ->
en:chronic renal failure
n1=en:mesangial matrix expansion | n2=en:chronic renal failure | rel=r_associated | relid=0 | w=37
- en:mesangial matrix expansion --
r_associated #0: 37 / 0.86 ->
en:dilated cystic tubules
n1=en:mesangial matrix expansion | n2=en:dilated cystic tubules | rel=r_associated | relid=0 | w=37
- en:mesangial matrix expansion --
r_associated #0: 36 / 0.837 ->
en:fetal pyelectasis
n1=en:mesangial matrix expansion | n2=en:fetal pyelectasis | rel=r_associated | relid=0 | w=36
- en:mesangial matrix expansion --
r_associated #0: 36 / 0.837 ->
en:horseshoe kidney (1 patient)
n1=en:mesangial matrix expansion | n2=en:horseshoe kidney (1 patient) | rel=r_associated | relid=0 | w=36
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:cystic dysplasia
n1=en:mesangial matrix expansion | n2=en:cystic dysplasia | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:cystic kidneys (may be observed prenatally)
n1=en:mesangial matrix expansion | n2=en:cystic kidneys (may be observed prenatally) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:cystic tubular dilatation in the cortex and medulla
n1=en:mesangial matrix expansion | n2=en:cystic tubular dilatation in the cortex and medulla | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:cysts contain eosinophilic proteinaceous material
n1=en:mesangial matrix expansion | n2=en:cysts contain eosinophilic proteinaceous material | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:decreased numbers of nephrons
n1=en:mesangial matrix expansion | n2=en:decreased numbers of nephrons | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:decreased renal function
n1=en:mesangial matrix expansion | n2=en:decreased renal function | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:denuded tubules
n1=en:mesangial matrix expansion | n2=en:denuded tubules | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:duplication of renal pelvis
n1=en:mesangial matrix expansion | n2=en:duplication of renal pelvis | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:end stage renal disease (33% of patients)
n1=en:mesangial matrix expansion | n2=en:end stage renal disease (33% of patients) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:exercise-induced acute renal failure with acute tubular necrosis
n1=en:mesangial matrix expansion | n2=en:exercise-induced acute renal failure with acute tubular necrosis | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:fanconi syndrome
n1=en:mesangial matrix expansion | n2=en:fanconi syndrome | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg
n1=en:mesangial matrix expansion | n2=en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:hydronephrosis (rare)
n1=en:mesangial matrix expansion | n2=en:hydronephrosis (rare) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:hypercalciuria
n1=en:mesangial matrix expansion | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:hypertension, moderate
n1=en:mesangial matrix expansion | n2=en:hypertension, moderate | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:immature podocytes
n1=en:mesangial matrix expansion | n2=en:immature podocytes | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:large nuclei (karyomegaly) in renal tubules seen renal biopsy
n1=en:mesangial matrix expansion | n2=en:large nuclei (karyomegaly) in renal tubules seen renal biopsy | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:mild subclinical decrease in renal function
n1=en:mesangial matrix expansion | n2=en:mild subclinical decrease in renal function | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:multicystic dysplastic kidneys (prenatal onset)
n1=en:mesangial matrix expansion | n2=en:multicystic dysplastic kidneys (prenatal onset) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:multiple renal cysts
n1=en:mesangial matrix expansion | n2=en:multiple renal cysts | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:narrowing of the ureteropelvic junctions
n1=en:mesangial matrix expansion | n2=en:narrowing of the ureteropelvic junctions | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:nephrolithiasis (rare)
n1=en:mesangial matrix expansion | n2=en:nephrolithiasis (rare) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:nephronophthisis (less common)
n1=en:mesangial matrix expansion | n2=en:nephronophthisis (less common) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:podocyte effacement
n1=en:mesangial matrix expansion | n2=en:podocyte effacement | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:pyelonephritis (in some patients)
n1=en:mesangial matrix expansion | n2=en:pyelonephritis (in some patients) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:rare mesangial igm deposition
n1=en:mesangial matrix expansion | n2=en:rare mesangial igm deposition | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:renal abnormalities
n1=en:mesangial matrix expansion | n2=en:renal abnormalities | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:renal aldosterone resistance
n1=en:mesangial matrix expansion | n2=en:renal aldosterone resistance | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:renal duplication (10%)
n1=en:mesangial matrix expansion | n2=en:renal duplication (10%) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 35 / 0.814 ->
en:renal malformation (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal malformation (in some patients) | rel=r_associated | relid=0 | w=35
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:abnormality of the renal collecting system
n1=en:mesangial matrix expansion | n2=en:abnormality of the renal collecting system | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:absent kidney
n1=en:mesangial matrix expansion | n2=en:absent kidney | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:absent renal function
n1=en:mesangial matrix expansion | n2=en:absent renal function | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:acute nephritis (rare)
n1=en:mesangial matrix expansion | n2=en:acute nephritis (rare) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:atrophic tubules
n1=en:mesangial matrix expansion | n2=en:atrophic tubules | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:bilateral hydronephrosis
n1=en:mesangial matrix expansion | n2=en:bilateral hydronephrosis | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:calcification of renal arteries
n1=en:mesangial matrix expansion | n2=en:calcification of renal arteries | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:calyceal dilation
n1=en:mesangial matrix expansion | n2=en:calyceal dilation | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:corticomedullary cysts
n1=en:mesangial matrix expansion | n2=en:corticomedullary cysts | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:cystic renal dysplasia
n1=en:mesangial matrix expansion | n2=en:cystic renal dysplasia | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:dilation of renal tubules, mild
n1=en:mesangial matrix expansion | n2=en:dilation of renal tubules, mild | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:focal tubular atrophy
n1=en:mesangial matrix expansion | n2=en:focal tubular atrophy | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:glomerulus
n1=en:mesangial matrix expansion | n2=en:glomerulus | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:hydronephrosis (in some patients)
n1=en:mesangial matrix expansion | n2=en:hydronephrosis (in some patients) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:impaired renal concentrating ability
n1=en:mesangial matrix expansion | n2=en:impaired renal concentrating ability | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:interstitial cell infiltrate
n1=en:mesangial matrix expansion | n2=en:interstitial cell infiltrate | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:nephron
n1=en:mesangial matrix expansion | n2=en:nephron | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:nephrosclerosis
n1=en:mesangial matrix expansion | n2=en:nephrosclerosis | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:pelvicalyceal dilatation
n1=en:mesangial matrix expansion | n2=en:pelvicalyceal dilatation | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:polyuria (in some)
n1=en:mesangial matrix expansion | n2=en:polyuria (in some) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal agenesis, unilateral (1 patient)
n1=en:mesangial matrix expansion | n2=en:renal agenesis, unilateral (1 patient) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal anomalies (less common)
n1=en:mesangial matrix expansion | n2=en:renal anomalies (less common) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal calcification (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal calcification (in some patients) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal calculi (rare)
n1=en:mesangial matrix expansion | n2=en:renal calculi (rare) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal cell
n1=en:mesangial matrix expansion | n2=en:renal cell | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal disease (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal disease (in some patients) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal insufficiency (in 2 of 3 siblings)
n1=en:mesangial matrix expansion | n2=en:renal insufficiency (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal pelvis
n1=en:mesangial matrix expansion | n2=en:renal pelvis | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 34 / 0.791 ->
en:renal potassium wasting
n1=en:mesangial matrix expansion | n2=en:renal potassium wasting | rel=r_associated | relid=0 | w=34
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:abnormal mitochondria in podocytes
n1=en:mesangial matrix expansion | n2=en:abnormal mitochondria in podocytes | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:adrenal hyperplasia
n1=en:mesangial matrix expansion | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:adrenal hypoplasia
n1=en:mesangial matrix expansion | n2=en:adrenal hypoplasia | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:bilateral renal hamartomas
n1=en:mesangial matrix expansion | n2=en:bilateral renal hamartomas | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:ectopic kidney
n1=en:mesangial matrix expansion | n2=en:ectopic kidney | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:ectopic kidney (2 patients)
n1=en:mesangial matrix expansion | n2=en:ectopic kidney (2 patients) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:focal segmental glomerulosclerosis (less common)
n1=en:mesangial matrix expansion | n2=en:focal segmental glomerulosclerosis (less common) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:heterotopic kidney
n1=en:mesangial matrix expansion | n2=en:heterotopic kidney | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:increased echogenicity of entire parenchyma
n1=en:mesangial matrix expansion | n2=en:increased echogenicity of entire parenchyma | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:increased renal tubular phosphate reabsorption
n1=en:mesangial matrix expansion | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:interstitial nephropathy
n1=en:mesangial matrix expansion | n2=en:interstitial nephropathy | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:isolated renal cyst (rare)
n1=en:mesangial matrix expansion | n2=en:isolated renal cyst (rare) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis
n1=en:mesangial matrix expansion | n2=en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:medullary sponge kidney (rare)
n1=en:mesangial matrix expansion | n2=en:medullary sponge kidney (rare) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:mesangial proliferative glomerulonephritis (in some patients)
n1=en:mesangial matrix expansion | n2=en:mesangial proliferative glomerulonephritis (in some patients) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:nephronophthisis (1 of 2 patients)
n1=en:mesangial matrix expansion | n2=en:nephronophthisis (1 of 2 patients) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:no evidence of renal cysts
n1=en:mesangial matrix expansion | n2=en:no evidence of renal cysts | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:no renal failure
n1=en:mesangial matrix expansion | n2=en:no renal failure | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal anomalies (in some)
n1=en:mesangial matrix expansion | n2=en:renal anomalies (in some) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal biopsy showed interstitial fibrosis
n1=en:mesangial matrix expansion | n2=en:renal biopsy showed interstitial fibrosis | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal cortex calcification (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal cortex calcification (in some patients) | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal failure in adulthood
n1=en:mesangial matrix expansion | n2=en:renal failure in adulthood | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal failure may occur with myoglobinuria
n1=en:mesangial matrix expansion | n2=en:renal failure may occur with myoglobinuria | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 32 / 0.744 ->
en:renal phosphate wasting
n1=en:mesangial matrix expansion | n2=en:renal phosphate wasting | rel=r_associated | relid=0 | w=32
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:acute renal failure
n1=en:mesangial matrix expansion | n2=en:acute renal failure | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:aneurysm of renal artery
n1=en:mesangial matrix expansion | n2=en:aneurysm of renal artery | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:biopsy shows decreased cytochrome c oxidase
n1=en:mesangial matrix expansion | n2=en:biopsy shows decreased cytochrome c oxidase | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:biopsy shows effacement of foot processes
n1=en:mesangial matrix expansion | n2=en:biopsy shows effacement of foot processes | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:cystic kidney
n1=en:mesangial matrix expansion | n2=en:cystic kidney | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:decreased kidney volume (1 patient)
n1=en:mesangial matrix expansion | n2=en:decreased kidney volume (1 patient) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:diffuse mesangial sclerosis (less common)
n1=en:mesangial matrix expansion | n2=en:diffuse mesangial sclerosis (less common) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:double renal pelvis (in some patients)
n1=en:mesangial matrix expansion | n2=en:double renal pelvis (in some patients) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:elevated aldosterone secretion
n1=en:mesangial matrix expansion | n2=en:elevated aldosterone secretion | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:enlarged kidneys due to extramedullary hematopoiesis
n1=en:mesangial matrix expansion | n2=en:enlarged kidneys due to extramedullary hematopoiesis | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:enlarged mitochondria with paracrystalline inclusions
n1=en:mesangial matrix expansion | n2=en:enlarged mitochondria with paracrystalline inclusions | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:glomerular filtration rate decreased
n1=en:mesangial matrix expansion | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:hemolytic uremic syndrome (in some patients)
n1=en:mesangial matrix expansion | n2=en:hemolytic uremic syndrome (in some patients) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:ipsilateral renal agenesis
n1=en:mesangial matrix expansion | n2=en:ipsilateral renal agenesis | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:minimal change disease on renal biopsy
n1=en:mesangial matrix expansion | n2=en:minimal change disease on renal biopsy | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:nephronophthisis
n1=en:mesangial matrix expansion | n2=en:nephronophthisis | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:pigmenturia
n1=en:mesangial matrix expansion | n2=en:pigmenturia | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:proximal tubulopathy
n1=en:mesangial matrix expansion | n2=en:proximal tubulopathy | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:proximal tubulopathy (1 patient)
n1=en:mesangial matrix expansion | n2=en:proximal tubulopathy (1 patient) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:reduced renal corticomedullary differentiation
n1=en:mesangial matrix expansion | n2=en:reduced renal corticomedullary differentiation | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal adysplasia
n1=en:mesangial matrix expansion | n2=en:renal adysplasia | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal amyloidosis, late-onset (uncommon)
n1=en:mesangial matrix expansion | n2=en:renal amyloidosis, late-onset (uncommon) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal biopsy shows glomerular sclerosis
n1=en:mesangial matrix expansion | n2=en:renal biopsy shows glomerular sclerosis | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal cysts (less common)
n1=en:mesangial matrix expansion | n2=en:renal cysts (less common) | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal failure, mild
n1=en:mesangial matrix expansion | n2=en:renal failure, mild | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal hypodysplasia
n1=en:mesangial matrix expansion | n2=en:renal hypodysplasia | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 31 / 0.721 ->
en:renal impairment
n1=en:mesangial matrix expansion | n2=en:renal impairment | rel=r_associated | relid=0 | w=31
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:a subset of patients develop renal insufficiency with decreased creatinine clearance
n1=en:mesangial matrix expansion | n2=en:a subset of patients develop renal insufficiency with decreased creatinine clearance | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:abnormal corticomedullary differentiation
n1=en:mesangial matrix expansion | n2=en:abnormal corticomedullary differentiation | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:amyloid nephropathy
n1=en:mesangial matrix expansion | n2=en:amyloid nephropathy | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:anomalous renal pelvis (rare)
n1=en:mesangial matrix expansion | n2=en:anomalous renal pelvis (rare) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:calcium oxalate urolithiasis
n1=en:mesangial matrix expansion | n2=en:calcium oxalate urolithiasis | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:complement component deposition
n1=en:mesangial matrix expansion | n2=en:complement component deposition | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:congenital hypoplasia of kidney
n1=en:mesangial matrix expansion | n2=en:congenital hypoplasia of kidney | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:duplicated collecting system (1 patient)
n1=en:mesangial matrix expansion | n2=en:duplicated collecting system (1 patient) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:glomerulonephropathy
n1=en:mesangial matrix expansion | n2=en:glomerulonephropathy | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos)
n1=en:mesangial matrix expansion | n2=en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:hyperplasia of zona glomerulosa of adrenal gland
n1=en:mesangial matrix expansion | n2=en:hyperplasia of zona glomerulosa of adrenal gland | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:hypoplastic/dysplastic kidney
n1=en:mesangial matrix expansion | n2=en:hypoplastic/dysplastic kidney | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:interstitial inflammation
n1=en:mesangial matrix expansion | n2=en:interstitial inflammation | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:intralobular nephrogenic rests
n1=en:mesangial matrix expansion | n2=en:intralobular nephrogenic rests | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:membranoproliferative glomerulonephritis (26%)
n1=en:mesangial matrix expansion | n2=en:membranoproliferative glomerulonephritis (26%) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:membranoproliferative glomerulonephritis (in some patients)
n1=en:mesangial matrix expansion | n2=en:membranoproliferative glomerulonephritis (in some patients) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:mild proteinuria (in some patients)
n1=en:mesangial matrix expansion | n2=en:mild proteinuria (in some patients) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:nephritis
n1=en:mesangial matrix expansion | n2=en:nephritis | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:nephroblastomatosis
n1=en:mesangial matrix expansion | n2=en:nephroblastomatosis | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:nephronophthisis (1 patient)
n1=en:mesangial matrix expansion | n2=en:nephronophthisis (1 patient) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:nephrotic syndrome
n1=en:mesangial matrix expansion | n2=en:nephrotic syndrome | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:no complement deposition
n1=en:mesangial matrix expansion | n2=en:no complement deposition | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:oligomeganephronia
n1=en:mesangial matrix expansion | n2=en:oligomeganephronia | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:pelviureteric junction obstruction
n1=en:mesangial matrix expansion | n2=en:pelviureteric junction obstruction | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:polycystic kidney disease
n1=en:mesangial matrix expansion | n2=en:polycystic kidney disease | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:primitive renal tubules may exist
n1=en:mesangial matrix expansion | n2=en:primitive renal tubules may exist | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:proteinuria
n1=en:mesangial matrix expansion | n2=en:proteinuria | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:renal biopsy shows diffuse mesangial sclerosis
n1=en:mesangial matrix expansion | n2=en:renal biopsy shows diffuse mesangial sclerosis | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:renal cystic dysplasia (1 patient)
n1=en:mesangial matrix expansion | n2=en:renal cystic dysplasia (1 patient) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:renal malrotation (rare)
n1=en:mesangial matrix expansion | n2=en:renal malrotation (rare) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:small medullary cysts
n1=en:mesangial matrix expansion | n2=en:small medullary cysts | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:structure of inferior pole of kidney
n1=en:mesangial matrix expansion | n2=en:structure of inferior pole of kidney | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:tubulointerstitial atrophy
n1=en:mesangial matrix expansion | n2=en:tubulointerstitial atrophy | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 30 / 0.698 ->
en:tubulopathy (1 family)
n1=en:mesangial matrix expansion | n2=en:tubulopathy (1 family) | rel=r_associated | relid=0 | w=30
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:abnormal glomeruli seen on biopsy
n1=en:mesangial matrix expansion | n2=en:abnormal glomeruli seen on biopsy | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:altered basement membrane
n1=en:mesangial matrix expansion | n2=en:altered basement membrane | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:atrophy of kidney
n1=en:mesangial matrix expansion | n2=en:atrophy of kidney | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:chronic/endstage renal failure
n1=en:mesangial matrix expansion | n2=en:chronic/endstage renal failure | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:collapsing fsgs
n1=en:mesangial matrix expansion | n2=en:collapsing fsgs | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:congenital nephrotic syndrome - diffuse mesangial sclerosis
n1=en:mesangial matrix expansion | n2=en:congenital nephrotic syndrome - diffuse mesangial sclerosis | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:cystic kidney disease
n1=en:mesangial matrix expansion | n2=en:cystic kidney disease | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:dilated bowman capsules
n1=en:mesangial matrix expansion | n2=en:dilated bowman capsules | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:dilated renal pelvis (rare)
n1=en:mesangial matrix expansion | n2=en:dilated renal pelvis (rare) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:discrete dilatation of the right kidney pelvis (rare)
n1=en:mesangial matrix expansion | n2=en:discrete dilatation of the right kidney pelvis (rare) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:early-onset end-stage renal disease
n1=en:mesangial matrix expansion | n2=en:early-onset end-stage renal disease | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy)
n1=en:mesangial matrix expansion | n2=en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:end-stage renal disease (in some patients)
n1=en:mesangial matrix expansion | n2=en:end-stage renal disease (in some patients) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:global glomerulosclerosis
n1=en:mesangial matrix expansion | n2=en:global glomerulosclerosis | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:glomerular basement membrane normal
n1=en:mesangial matrix expansion | n2=en:glomerular basement membrane normal | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:glomerular crescents (rare), seen on biopsy
n1=en:mesangial matrix expansion | n2=en:glomerular crescents (rare), seen on biopsy | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:hemoglobinuria (in some patients)
n1=en:mesangial matrix expansion | n2=en:hemoglobinuria (in some patients) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:hyperchromatic nuclei
n1=en:mesangial matrix expansion | n2=en:hyperchromatic nuclei | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:hyperuricemia
n1=en:mesangial matrix expansion | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:increased mesangial matrix
n1=en:mesangial matrix expansion | n2=en:increased mesangial matrix | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:malrotation of kidney
n1=en:mesangial matrix expansion | n2=en:malrotation of kidney | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:median onset of renal failure 19 years
n1=en:mesangial matrix expansion | n2=en:median onset of renal failure 19 years | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:medullary cystic disease
n1=en:mesangial matrix expansion | n2=en:medullary cystic disease | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:medullary cystic renal disease
n1=en:mesangial matrix expansion | n2=en:medullary cystic renal disease | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:microcystic kidney
n1=en:mesangial matrix expansion | n2=en:microcystic kidney | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:nephritis, acute tubulointerstitial (mononuclear infiltrate)
n1=en:mesangial matrix expansion | n2=en:nephritis, acute tubulointerstitial (mononuclear infiltrate) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:nephrocalcinosis (in some patients)
n1=en:mesangial matrix expansion | n2=en:nephrocalcinosis (in some patients) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:nephrogenic rests (rare, in males)
n1=en:mesangial matrix expansion | n2=en:nephrogenic rests (rare, in males) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:nephrotic syndrome (1 patient)
n1=en:mesangial matrix expansion | n2=en:nephrotic syndrome (1 patient) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:no nephritis
n1=en:mesangial matrix expansion | n2=en:no nephritis | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:pelvic dilation
n1=en:mesangial matrix expansion | n2=en:pelvic dilation | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:pseudomembranous, calcified plaques in the renal collecting system (rare)
n1=en:mesangial matrix expansion | n2=en:pseudomembranous, calcified plaques in the renal collecting system (rare) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:reduced excretion of calcium
n1=en:mesangial matrix expansion | n2=en:reduced excretion of calcium | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal aplasia (less common)
n1=en:mesangial matrix expansion | n2=en:renal aplasia (less common) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal cysts (33%)
n1=en:mesangial matrix expansion | n2=en:renal cysts (33%) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal dysplasia/aplasia
n1=en:mesangial matrix expansion | n2=en:renal dysplasia/aplasia | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal failure by age 3
n1=en:mesangial matrix expansion | n2=en:renal failure by age 3 | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal mesangiolipidosis
n1=en:mesangial matrix expansion | n2=en:renal mesangiolipidosis | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:renal tubular cell atrophy with corticomedullary cysts
n1=en:mesangial matrix expansion | n2=en:renal tubular cell atrophy with corticomedullary cysts | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:sclerosing glomerulonephropathy
n1=en:mesangial matrix expansion | n2=en:sclerosing glomerulonephropathy | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:small echogenic kidneys
n1=en:mesangial matrix expansion | n2=en:small echogenic kidneys | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 29 / 0.674 ->
en:tumors of the kidney (may progress to malignancy in less than 2%)
n1=en:mesangial matrix expansion | n2=en:tumors of the kidney (may progress to malignancy in less than 2%) | rel=r_associated | relid=0 | w=29
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:abnormal renal pelvises
n1=en:mesangial matrix expansion | n2=en:abnormal renal pelvises | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:adult onset polycystic kidney (50%)
n1=en:mesangial matrix expansion | n2=en:adult onset polycystic kidney (50%) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:anuria
n1=en:mesangial matrix expansion | n2=en:anuria | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:calcinosis of the renal parenchyma
n1=en:mesangial matrix expansion | n2=en:calcinosis of the renal parenchyma | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:calcium nephrolithiasis
n1=en:mesangial matrix expansion | n2=en:calcium nephrolithiasis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:chronic interstitial nephritis
n1=en:mesangial matrix expansion | n2=en:chronic interstitial nephritis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:chronic nephritis
n1=en:mesangial matrix expansion | n2=en:chronic nephritis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:congenital absence of kidney
n1=en:mesangial matrix expansion | n2=en:congenital absence of kidney | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:cystic changes in the kidney
n1=en:mesangial matrix expansion | n2=en:cystic changes in the kidney | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:foot process effacement
n1=en:mesangial matrix expansion | n2=en:foot process effacement | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:fused kidney
n1=en:mesangial matrix expansion | n2=en:fused kidney | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection)
n1=en:mesangial matrix expansion | n2=en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:hydronephrosis
n1=en:mesangial matrix expansion | n2=en:hydronephrosis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:hyperplasia
n1=en:mesangial matrix expansion | n2=en:hyperplasia | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:hypoplastic glomerulocystic kidney disease
n1=en:mesangial matrix expansion | n2=en:hypoplastic glomerulocystic kidney disease | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:increased echogenicity (1 of 2 patients)
n1=en:mesangial matrix expansion | n2=en:increased echogenicity (1 of 2 patients) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:increased glomerular cellularity
n1=en:mesangial matrix expansion | n2=en:increased glomerular cellularity | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:kidney disorder
n1=en:mesangial matrix expansion | n2=en:kidney disorder | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:microcystic change
n1=en:mesangial matrix expansion | n2=en:microcystic change | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:microcystic dysplasia
n1=en:mesangial matrix expansion | n2=en:microcystic dysplasia | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:nephrocalcinosis
n1=en:mesangial matrix expansion | n2=en:nephrocalcinosis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:nephrolithiasis (hcs and 2p21del)
n1=en:mesangial matrix expansion | n2=en:nephrolithiasis (hcs and 2p21del) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:normal kidneys
n1=en:mesangial matrix expansion | n2=en:normal kidneys | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:normal renal ultrasound at ages 4 and 7
n1=en:mesangial matrix expansion | n2=en:normal renal ultrasound at ages 4 and 7 | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:pelvic kidney
n1=en:mesangial matrix expansion | n2=en:pelvic kidney | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:podocytes show microvillous transformation
n1=en:mesangial matrix expansion | n2=en:podocytes show microvillous transformation | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:progressive renal failure
n1=en:mesangial matrix expansion | n2=en:progressive renal failure | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:proteinuria (rare)
n1=en:mesangial matrix expansion | n2=en:proteinuria (rare) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal abnormalities (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal abnormalities (in some patients) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal anomalies (27%)
n1=en:mesangial matrix expansion | n2=en:renal anomalies (27%) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal anomalies (67% of patients)
n1=en:mesangial matrix expansion | n2=en:renal anomalies (67% of patients) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal biopsy shows tubulointerstitial fibrosis
n1=en:mesangial matrix expansion | n2=en:renal biopsy shows tubulointerstitial fibrosis | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal cortex
n1=en:mesangial matrix expansion | n2=en:renal cortex | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal cortical cysts
n1=en:mesangial matrix expansion | n2=en:renal cortical cysts | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal failure
n1=en:mesangial matrix expansion | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal hamartoma
n1=en:mesangial matrix expansion | n2=en:renal hamartoma | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal hypoplasia/aplasia
n1=en:mesangial matrix expansion | n2=en:renal hypoplasia/aplasia | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:renal stones (in one patient)
n1=en:mesangial matrix expansion | n2=en:renal stones (in one patient) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:small kidneys (in some patients)
n1=en:mesangial matrix expansion | n2=en:small kidneys (in some patients) | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:thickening of the glomerular basement membrane on renal biopsy
n1=en:mesangial matrix expansion | n2=en:thickening of the glomerular basement membrane on renal biopsy | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 28 / 0.651 ->
en:uriniferous tubule
n1=en:mesangial matrix expansion | n2=en:uriniferous tubule | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:abnormal renal calyces
n1=en:mesangial matrix expansion | n2=en:abnormal renal calyces | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:chronic kidney insufficiency
n1=en:mesangial matrix expansion | n2=en:chronic kidney insufficiency | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:dark urine following exercise
n1=en:mesangial matrix expansion | n2=en:dark urine following exercise | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:decreased tubular resorption of phosphate (in some patients)
n1=en:mesangial matrix expansion | n2=en:decreased tubular resorption of phosphate (in some patients) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:defective urinary concentrating ability
n1=en:mesangial matrix expansion | n2=en:defective urinary concentrating ability | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:degenerative cysts
n1=en:mesangial matrix expansion | n2=en:degenerative cysts | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:dilated calyces (rare)
n1=en:mesangial matrix expansion | n2=en:dilated calyces (rare) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:effacement of podocyte foot processes
n1=en:mesangial matrix expansion | n2=en:effacement of podocyte foot processes | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:end-stage renal disease (in some)
n1=en:mesangial matrix expansion | n2=en:end-stage renal disease (in some) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:end-stage renal failure (in some patients)
n1=en:mesangial matrix expansion | n2=en:end-stage renal failure (in some patients) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:focal cystic changes
n1=en:mesangial matrix expansion | n2=en:focal cystic changes | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:focal medullary hypoplasia
n1=en:mesangial matrix expansion | n2=en:focal medullary hypoplasia | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:glomerular and renal tubular cysts
n1=en:mesangial matrix expansion | n2=en:glomerular and renal tubular cysts | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:glomerular dysfunction (variable)
n1=en:mesangial matrix expansion | n2=en:glomerular dysfunction (variable) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:hypomagnesemia 2, renal
n1=en:mesangial matrix expansion | n2=en:hypomagnesemia 2, renal | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:impaired renal function (variable)
n1=en:mesangial matrix expansion | n2=en:impaired renal function (variable) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:kidney transplantation
n1=en:mesangial matrix expansion | n2=en:kidney transplantation | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:minimal change disease (lipoid nephrosis) on renal biopsy
n1=en:mesangial matrix expansion | n2=en:minimal change disease (lipoid nephrosis) on renal biopsy | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:nephrocalcinosis is absent
n1=en:mesangial matrix expansion | n2=en:nephrocalcinosis is absent | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:nephronophthisis-like nephropathy
n1=en:mesangial matrix expansion | n2=en:nephronophthisis-like nephropathy | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:normal distal tubule acid excretion
n1=en:mesangial matrix expansion | n2=en:normal distal tubule acid excretion | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:patchy deposition of igg and igm
n1=en:mesangial matrix expansion | n2=en:patchy deposition of igg and igm | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:proximal renal tubular acidosis
n1=en:mesangial matrix expansion | n2=en:proximal renal tubular acidosis | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal biopsy shows tubular atrophy
n1=en:mesangial matrix expansion | n2=en:renal biopsy shows tubular atrophy | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal dysplasia (wws)
n1=en:mesangial matrix expansion | n2=en:renal dysplasia (wws) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal failure (most common cause of death) (iowa type 107680.0010)
n1=en:mesangial matrix expansion | n2=en:renal failure (most common cause of death) (iowa type 107680.0010) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal failure, slowly progressive
n1=en:mesangial matrix expansion | n2=en:renal failure, slowly progressive | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal hypoplasia (rare)
n1=en:mesangial matrix expansion | n2=en:renal hypoplasia (rare) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal juxtaglomerular cell hypertrophy/hyperplasia
n1=en:mesangial matrix expansion | n2=en:renal juxtaglomerular cell hypertrophy/hyperplasia | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal scarring
n1=en:mesangial matrix expansion | n2=en:renal scarring | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:renal stones, bilateral
n1=en:mesangial matrix expansion | n2=en:renal stones, bilateral | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:some sclerotic glomeruli
n1=en:mesangial matrix expansion | n2=en:some sclerotic glomeruli | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:unilateral renal agenesis
n1=en:mesangial matrix expansion | n2=en:unilateral renal agenesis | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 27 / 0.628 ->
en:urinary tract dilatation (in some patients)
n1=en:mesangial matrix expansion | n2=en:urinary tract dilatation (in some patients) | rel=r_associated | relid=0 | w=27
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:absence of renal corticomedullary differentiation
n1=en:mesangial matrix expansion | n2=en:absence of renal corticomedullary differentiation | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:absent kidneys (rare)
n1=en:mesangial matrix expansion | n2=en:absent kidneys (rare) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:antibody deposits
n1=en:mesangial matrix expansion | n2=en:antibody deposits | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:deposition of complement component c3 in glomerular basement membrane
n1=en:mesangial matrix expansion | n2=en:deposition of complement component c3 in glomerular basement membrane | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:deposition of igg and complement seen on renal biopsy (in some patients)
n1=en:mesangial matrix expansion | n2=en:deposition of igg and complement seen on renal biopsy (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:echogenic kidneys
n1=en:mesangial matrix expansion | n2=en:echogenic kidneys | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:end-stage renal disease by third decade of life
n1=en:mesangial matrix expansion | n2=en:end-stage renal disease by third decade of life | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:enlarged glomeruli
n1=en:mesangial matrix expansion | n2=en:enlarged glomeruli | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:glomerulocystic dysplasia
n1=en:mesangial matrix expansion | n2=en:glomerulocystic dysplasia | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:glomerulosclerosis and fibrosis
n1=en:mesangial matrix expansion | n2=en:glomerulosclerosis and fibrosis | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:granular material in cortical tubules
n1=en:mesangial matrix expansion | n2=en:granular material in cortical tubules | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:histologically normal adrenal gland (in some patients)
n1=en:mesangial matrix expansion | n2=en:histologically normal adrenal gland (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:hyperechogenic kidneys (in some patients)
n1=en:mesangial matrix expansion | n2=en:hyperechogenic kidneys (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:hypoplastic kidneys (in some patients)
n1=en:mesangial matrix expansion | n2=en:hypoplastic kidneys (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:hypotonic urine (in some patients)
n1=en:mesangial matrix expansion | n2=en:hypotonic urine (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:impaired reabsorption of chloride
n1=en:mesangial matrix expansion | n2=en:impaired reabsorption of chloride | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:increased renal salt reabsorption
n1=en:mesangial matrix expansion | n2=en:increased renal salt reabsorption | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:kidney biopsy shows absence of differentiated proximal tubules
n1=en:mesangial matrix expansion | n2=en:kidney biopsy shows absence of differentiated proximal tubules | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:lipid accumulation in kidney, especially in proximal convoluted tubules
n1=en:mesangial matrix expansion | n2=en:lipid accumulation in kidney, especially in proximal convoluted tubules | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin
n1=en:mesangial matrix expansion | n2=en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:microcystic tubular dilatations
n1=en:mesangial matrix expansion | n2=en:microcystic tubular dilatations | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:microvillus transformation of the podocytes
n1=en:mesangial matrix expansion | n2=en:microvillus transformation of the podocytes | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:multicystic kidney (rare, in males)
n1=en:mesangial matrix expansion | n2=en:multicystic kidney (rare, in males) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:polyuria (in some patients)
n1=en:mesangial matrix expansion | n2=en:polyuria (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:proteinuria (in 2 of 3 siblings)
n1=en:mesangial matrix expansion | n2=en:proteinuria (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:recurrent urinary tract infection
n1=en:mesangial matrix expansion | n2=en:recurrent urinary tract infection | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal cell carcinoma (e.g., 193300.0002)
n1=en:mesangial matrix expansion | n2=en:renal cell carcinoma (e.g., 193300.0002) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal corticomedullary cysts
n1=en:mesangial matrix expansion | n2=en:renal corticomedullary cysts | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal hypoplasia (less common)
n1=en:mesangial matrix expansion | n2=en:renal hypoplasia (less common) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal interstitial fibrosis
n1=en:mesangial matrix expansion | n2=en:renal interstitial fibrosis | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal medulla
n1=en:mesangial matrix expansion | n2=en:renal medulla | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:renal tubular acidosis (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal tubular acidosis (in some patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:structural abnormalities, mild
n1=en:mesangial matrix expansion | n2=en:structural abnormalities, mild | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:thickening of glomerular basement membrane
n1=en:mesangial matrix expansion | n2=en:thickening of glomerular basement membrane | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:tubular dilation (1 of 2 patients)
n1=en:mesangial matrix expansion | n2=en:tubular dilation (1 of 2 patients) | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 26 / 0.605 ->
en:uromodulin reduced or absent in urine
n1=en:mesangial matrix expansion | n2=en:uromodulin reduced or absent in urine | rel=r_associated | relid=0 | w=26
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:absence of corticomedullary differentiation (ultrasound)
n1=en:mesangial matrix expansion | n2=en:absence of corticomedullary differentiation (ultrasound) | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:biopsy shows dilated proximal tubules
n1=en:mesangial matrix expansion | n2=en:biopsy shows dilated proximal tubules | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:calcium oxalate/carbonate urolithiasis
n1=en:mesangial matrix expansion | n2=en:calcium oxalate/carbonate urolithiasis | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:duplex renal system
n1=en:mesangial matrix expansion | n2=en:duplex renal system | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:hydronephrosis (male)
n1=en:mesangial matrix expansion | n2=en:hydronephrosis (male) | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:immune complex nephritis
n1=en:mesangial matrix expansion | n2=en:immune complex nephritis | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:kidney cyst
n1=en:mesangial matrix expansion | n2=en:kidney cyst | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:polycystic kidney - body part
n1=en:mesangial matrix expansion | n2=en:polycystic kidney - body part | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:renal cysts (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal cysts (in some patients) | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:renal phosphate wasting (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal phosphate wasting (in some patients) | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 25 / 0.581 ->
en:thickening of the glomerular basement membrane (later in the disease)
n1=en:mesangial matrix expansion | n2=en:thickening of the glomerular basement membrane (later in the disease) | rel=r_associated | relid=0 | w=25
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:adrenal hyperplasia, bilateral
n1=en:mesangial matrix expansion | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:bicarbonate-wasting renal tubular acidosis
n1=en:mesangial matrix expansion | n2=en:bicarbonate-wasting renal tubular acidosis | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:focal glomerulosclerosis (in 33%)
n1=en:mesangial matrix expansion | n2=en:focal glomerulosclerosis (in 33%) | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:impaired renal absorption of cationic amino acids
n1=en:mesangial matrix expansion | n2=en:impaired renal absorption of cationic amino acids | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:nephrocalcinosis (rare)
n1=en:mesangial matrix expansion | n2=en:nephrocalcinosis (rare) | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:nephronophthisis (rare)
n1=en:mesangial matrix expansion | n2=en:nephronophthisis (rare) | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:reduced renal function (in some patients with structural anomalies)
n1=en:mesangial matrix expansion | n2=en:reduced renal function (in some patients with structural anomalies) | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:renal colic (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal colic (in some patients) | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:renal parenchymal disease
n1=en:mesangial matrix expansion | n2=en:renal parenchymal disease | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:secondary renal insufficiency
n1=en:mesangial matrix expansion | n2=en:secondary renal insufficiency | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:structure of superior pole of kidney
n1=en:mesangial matrix expansion | n2=en:structure of superior pole of kidney | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:swelling of endothelial cells
n1=en:mesangial matrix expansion | n2=en:swelling of endothelial cells | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 24 / 0.558 ->
en:ultrasound shows hyperechoic kidneys
n1=en:mesangial matrix expansion | n2=en:ultrasound shows hyperechoic kidneys | rel=r_associated | relid=0 | w=24
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:low fractional excretion of uric acid
n1=en:mesangial matrix expansion | n2=en:low fractional excretion of uric acid | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:nephrotic syndrome (in some patients)
n1=en:mesangial matrix expansion | n2=en:nephrotic syndrome (in some patients) | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:no kidney disease
n1=en:mesangial matrix expansion | n2=en:no kidney disease | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:normal glomerular function
n1=en:mesangial matrix expansion | n2=en:normal glomerular function | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:renal disease, uncharacterized (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal disease, uncharacterized (in some patients) | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:renal sodium wasting
n1=en:mesangial matrix expansion | n2=en:renal sodium wasting | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 23 / 0.535 ->
en:segmental capillary wall thickening
n1=en:mesangial matrix expansion | n2=en:segmental capillary wall thickening | rel=r_associated | relid=0 | w=23
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:attenuation of the glomerular basement membrane
n1=en:mesangial matrix expansion | n2=en:attenuation of the glomerular basement membrane | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:entire kidney
n1=en:mesangial matrix expansion | n2=en:entire kidney | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:horseshoe kidney (rare)
n1=en:mesangial matrix expansion | n2=en:horseshoe kidney (rare) | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:membranoproliferative glomerulonephritis (in about 26%)
n1=en:mesangial matrix expansion | n2=en:membranoproliferative glomerulonephritis (in about 26%) | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:microscopic hematuria
n1=en:mesangial matrix expansion | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:nephrogenic diabetes insipidus (less common)
n1=en:mesangial matrix expansion | n2=en:nephrogenic diabetes insipidus (less common) | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:polyuria
n1=en:mesangial matrix expansion | n2=en:polyuria | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:proximal tubulopathy, generalized
n1=en:mesangial matrix expansion | n2=en:proximal tubulopathy, generalized | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:renal cysts (1 patient)
n1=en:mesangial matrix expansion | n2=en:renal cysts (1 patient) | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:small echogenic kidneys (in some patients)
n1=en:mesangial matrix expansion | n2=en:small echogenic kidneys (in some patients) | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 22 / 0.512 ->
en:swollen podocytes
n1=en:mesangial matrix expansion | n2=en:swollen podocytes | rel=r_associated | relid=0 | w=22
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:adrenal cortex atrophy (42%)
n1=en:mesangial matrix expansion | n2=en:adrenal cortex atrophy (42%) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas
n1=en:mesangial matrix expansion | n2=en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:cystic kidneys (rare)
n1=en:mesangial matrix expansion | n2=en:cystic kidneys (rare) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:cystic tubular dilatation in the corticomedullary area and medulla
n1=en:mesangial matrix expansion | n2=en:cystic tubular dilatation in the corticomedullary area and medulla | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:duplicated kidneys (rare)
n1=en:mesangial matrix expansion | n2=en:duplicated kidneys (rare) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:dysplastic renal parenchyma
n1=en:mesangial matrix expansion | n2=en:dysplastic renal parenchyma | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:electron microscopy shows foot-process effacement
n1=en:mesangial matrix expansion | n2=en:electron microscopy shows foot-process effacement | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:enlarged kidney
n1=en:mesangial matrix expansion | n2=en:enlarged kidney | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:hypoaldosteronism, hyporeninemic
n1=en:mesangial matrix expansion | n2=en:hypoaldosteronism, hyporeninemic | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:hypoplastic renal arteries (rare)
n1=en:mesangial matrix expansion | n2=en:hypoplastic renal arteries (rare) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:kidney part
n1=en:mesangial matrix expansion | n2=en:kidney part | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:kidney wilms tumor
n1=en:mesangial matrix expansion | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:multicystic dysplastic kidney
n1=en:mesangial matrix expansion | n2=en:multicystic dysplastic kidney | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:perihilar mesangial deposition of proteinaceous material
n1=en:mesangial matrix expansion | n2=en:perihilar mesangial deposition of proteinaceous material | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:renal agenesis, left-sided (1/4 patients)
n1=en:mesangial matrix expansion | n2=en:renal agenesis, left-sided (1/4 patients) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:renal biopsy shows chronic interstitial nephritis
n1=en:mesangial matrix expansion | n2=en:renal biopsy shows chronic interstitial nephritis | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:renal failure, endstage (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal failure, endstage (in some patients) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:renal hemangioblastoma
n1=en:mesangial matrix expansion | n2=en:renal hemangioblastoma | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:renal tubular degeneration
n1=en:mesangial matrix expansion | n2=en:renal tubular degeneration | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:small kidney (reported in 1 patient)
n1=en:mesangial matrix expansion | n2=en:small kidney (reported in 1 patient) | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:tabular atrophy
n1=en:mesangial matrix expansion | n2=en:tabular atrophy | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:thickening and disorganization of the glomerular basement membrane
n1=en:mesangial matrix expansion | n2=en:thickening and disorganization of the glomerular basement membrane | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 21 / 0.488 ->
en:tubular cysts
n1=en:mesangial matrix expansion | n2=en:tubular cysts | rel=r_associated | relid=0 | w=21
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
anurie
n1=en:mesangial matrix expansion | n2=anurie | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
défaillance du rein
n1=en:mesangial matrix expansion | n2=défaillance du rein | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
défaillance rénale
n1=en:mesangial matrix expansion | n2=défaillance rénale | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
défaillance rénale chronique
n1=en:mesangial matrix expansion | n2=défaillance rénale chronique | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:chronic kidney disease
n1=en:mesangial matrix expansion | n2=en:chronic kidney disease | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:chronic kidney failure
n1=en:mesangial matrix expansion | n2=en:chronic kidney failure | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:chronic renal dysfunction/failure
n1=en:mesangial matrix expansion | n2=en:chronic renal dysfunction/failure | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:cystic nephroma
n1=en:mesangial matrix expansion | n2=en:cystic nephroma | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:duplicated kidney (in some patients)
n1=en:mesangial matrix expansion | n2=en:duplicated kidney (in some patients) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:exercise-induced acute renal failure (in some patients)
n1=en:mesangial matrix expansion | n2=en:exercise-induced acute renal failure (in some patients) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:focal segmental glomerulosclerosis
n1=en:mesangial matrix expansion | n2=en:focal segmental glomerulosclerosis | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:glomerulonephiitis
n1=en:mesangial matrix expansion | n2=en:glomerulonephiitis | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:glomerulonephritis
n1=en:mesangial matrix expansion | n2=en:glomerulonephritis | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:hematuria
n1=en:mesangial matrix expansion | n2=en:hematuria | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:hemolytic-uremic syndrome requiring dialysis (1 patient)
n1=en:mesangial matrix expansion | n2=en:hemolytic-uremic syndrome requiring dialysis (1 patient) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:increased urinary excretion of uric acid
n1=en:mesangial matrix expansion | n2=en:increased urinary excretion of uric acid | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:kidney diseases
n1=en:mesangial matrix expansion | n2=en:kidney diseases | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:kidney failure
n1=en:mesangial matrix expansion | n2=en:kidney failure | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:multiple calyceal cysts
n1=en:mesangial matrix expansion | n2=en:multiple calyceal cysts | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:nephronum
n1=en:mesangial matrix expansion | n2=en:nephronum | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:renal capsule
n1=en:mesangial matrix expansion | n2=en:renal capsule | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:renal insufficiency
n1=en:mesangial matrix expansion | n2=en:renal insufficiency | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:renal stones (in some patients)
n1=en:mesangial matrix expansion | n2=en:renal stones (in some patients) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:renal tubulopathy (patient a)
n1=en:mesangial matrix expansion | n2=en:renal tubulopathy (patient a) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
en:uric acid nephrolithiasis
n1=en:mesangial matrix expansion | n2=en:uric acid nephrolithiasis | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
glomérulite
n1=en:mesangial matrix expansion | n2=glomérulite | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
glomérulonéphrite
n1=en:mesangial matrix expansion | n2=glomérulonéphrite | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
glomerulonéphrite
n1=en:mesangial matrix expansion | n2=glomerulonéphrite | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
glomérulonéphrite extra-membraneuse
n1=en:mesangial matrix expansion | n2=glomérulonéphrite extra-membraneuse | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
glomérulonéphrite extramembraneuse
n1=en:mesangial matrix expansion | n2=glomérulonéphrite extramembraneuse | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
gros rein
n1=en:mesangial matrix expansion | n2=gros rein | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
hématurie
n1=en:mesangial matrix expansion | n2=hématurie | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
hématurie macroscopique
n1=en:mesangial matrix expansion | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
hématurie microscopique
n1=en:mesangial matrix expansion | n2=hématurie microscopique | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
hypercalciurie
n1=en:mesangial matrix expansion | n2=hypercalciurie | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
hypoaldostéronisme hyporéninémique
n1=en:mesangial matrix expansion | n2=hypoaldostéronisme hyporéninémique | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale
n1=en:mesangial matrix expansion | n2=insuffisance rénale | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale (neuropathie et)
n1=en:mesangial matrix expansion | n2=insuffisance rénale (neuropathie et) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
Insuffisance rénale aiguë
n1=en:mesangial matrix expansion | n2=Insuffisance rénale aiguë | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale aiguë
n1=en:mesangial matrix expansion | n2=insuffisance rénale aiguë | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale aigüe
n1=en:mesangial matrix expansion | n2=insuffisance rénale aigüe | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale chronique
n1=en:mesangial matrix expansion | n2=insuffisance rénale chronique | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
insuffisance rénale non précisée
n1=en:mesangial matrix expansion | n2=insuffisance rénale non précisée | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
IRC
n1=en:mesangial matrix expansion | n2=IRC | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
IRC
(médecine)
n1=en:mesangial matrix expansion | n2=IRC (médecine) | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
néphrite
n1=en:mesangial matrix expansion | n2=néphrite | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
néphroblastomatose
n1=en:mesangial matrix expansion | n2=néphroblastomatose | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
néphrocalcinose
n1=en:mesangial matrix expansion | n2=néphrocalcinose | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
néphron
n1=en:mesangial matrix expansion | n2=néphron | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
néphropathie amyloïde
n1=en:mesangial matrix expansion | n2=néphropathie amyloïde | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
non précisée, insuffisance rénale
n1=en:mesangial matrix expansion | n2=non précisée, insuffisance rénale | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
polyurie
n1=en:mesangial matrix expansion | n2=polyurie | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
syndrome d'insuffisance rénale
n1=en:mesangial matrix expansion | n2=syndrome d'insuffisance rénale | rel=r_associated | relid=0 | w=20
- en:mesangial matrix expansion --
r_associated #0: 20 / 0.465 ->
tubule rénal
n1=en:mesangial matrix expansion | n2=tubule rénal | rel=r_associated | relid=0 | w=20
| ≈ 474 relations entrantes
- en:kidney diseases ---
r_associated #0: 305 -->
en:mesangial matrix expansion
n1=en:kidney diseases | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=305
- en:amyloid nephropathy ---
r_associated #0: 192 -->
en:mesangial matrix expansion
n1=en:amyloid nephropathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=192
- néphropathie amyloïde ---
r_associated #0: 190 -->
en:mesangial matrix expansion
n1=néphropathie amyloïde | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=190
- défaillance rénale chronique ---
r_associated #0: 170 -->
en:mesangial matrix expansion
n1=défaillance rénale chronique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=170
- en:chronic kidney insufficiency ---
r_associated #0: 169 -->
en:mesangial matrix expansion
n1=en:chronic kidney insufficiency | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=169
- insuffisance rénale chronique ---
r_associated #0: 161 -->
en:mesangial matrix expansion
n1=insuffisance rénale chronique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=161
- IRC
(médecine) ---
r_associated #0: 160 -->
en:mesangial matrix expansion
n1=IRC (médecine) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=160
- en:kidney failure ---
r_associated #0: 148 -->
en:mesangial matrix expansion
n1=en:kidney failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=148
- défaillance du rein ---
r_associated #0: 145 -->
en:mesangial matrix expansion
n1=défaillance du rein | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=145
- en:chronic kidney failure ---
r_associated #0: 145 -->
en:mesangial matrix expansion
n1=en:chronic kidney failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=145
- insuffisance rénale ---
r_associated #0: 145 -->
en:mesangial matrix expansion
n1=insuffisance rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=145
- en:renal failure ---
r_associated #0: 144 -->
en:mesangial matrix expansion
n1=en:renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=144
- en:glomerulonephritis ---
r_associated #0: 104 -->
en:mesangial matrix expansion
n1=en:glomerulonephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=104
- glomérulonéphrite ---
r_associated #0: 104 -->
en:mesangial matrix expansion
n1=glomérulonéphrite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=104
- glomerulonéphrite ---
r_associated #0: 101 -->
en:mesangial matrix expansion
n1=glomerulonéphrite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=101
- défaillance rénale ---
r_associated #0: 98 -->
en:mesangial matrix expansion
n1=défaillance rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=98
- insuffisance rénale non précisée ---
r_associated #0: 98 -->
en:mesangial matrix expansion
n1=insuffisance rénale non précisée | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=98
- syndrome d'insuffisance rénale ---
r_associated #0: 95 -->
en:mesangial matrix expansion
n1=syndrome d'insuffisance rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=95
- non précisée, insuffisance rénale ---
r_associated #0: 94 -->
en:mesangial matrix expansion
n1=non précisée, insuffisance rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=94
- néphrite ---
r_associated #0: 82 -->
en:mesangial matrix expansion
n1=néphrite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=82
- en:nephritis ---
r_associated #0: 80 -->
en:mesangial matrix expansion
n1=en:nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=80
- insuffisance rénale aiguë ---
r_associated #0: 80 -->
en:mesangial matrix expansion
n1=insuffisance rénale aiguë | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=80
- en:acute renal failure ---
r_associated #0: 76 -->
en:mesangial matrix expansion
n1=en:acute renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=76
- néphron ---
r_associated #0: 58 -->
en:mesangial matrix expansion
n1=néphron | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=58
- IRC ---
r_associated #0: 55 -->
en:mesangial matrix expansion
n1=IRC | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=55
- en:chronic renal failure ---
r_associated #0: 55 -->
en:mesangial matrix expansion
n1=en:chronic renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=55
- en:nephron ---
r_associated #0: 55 -->
en:mesangial matrix expansion
n1=en:nephron | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=55
- en:renal insufficiency ---
r_associated #0: 55 -->
en:mesangial matrix expansion
n1=en:renal insufficiency | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=55
- Insuffisance rénale aiguë ---
r_associated #0: 50 -->
en:mesangial matrix expansion
n1=Insuffisance rénale aiguë | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=50
- en:loss of podocyte foot processes ---
r_associated #0: 43 -->
en:mesangial matrix expansion
n1=en:loss of podocyte foot processes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=43
- polyurie ---
r_associated #0: 43 -->
en:mesangial matrix expansion
n1=polyurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=43
- en:a subset of patients develop renal insufficiency with decreased creatinine clearance ---
r_associated #0: 42 -->
en:mesangial matrix expansion
n1=en:a subset of patients develop renal insufficiency with decreased creatinine clearance | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=42
- en:hematuria, gross (in some patients) ---
r_associated #0: 42 -->
en:mesangial matrix expansion
n1=en:hematuria, gross (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=42
- en:normal glomerular function ---
r_associated #0: 42 -->
en:mesangial matrix expansion
n1=en:normal glomerular function | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=42
- en:polyuria ---
r_associated #0: 42 -->
en:mesangial matrix expansion
n1=en:polyuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=42
- glomérulonéphrite extramembraneuse ---
r_associated #0: 42 -->
en:mesangial matrix expansion
n1=glomérulonéphrite extramembraneuse | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=42
- en:absence of corticomedullary differentiation (ultrasound) ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:absence of corticomedullary differentiation (ultrasound) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:cystic tubular dilatation in the corticomedullary area and medulla ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:cystic tubular dilatation in the corticomedullary area and medulla | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:multiple calyceal cysts ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:multiple calyceal cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:primitive renal tubules may exist ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:primitive renal tubules may exist | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:renal hypoplasia (rare) ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:renal hypoplasia (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:renal tubulopathy (patient a) ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=en:renal tubulopathy (patient a) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- glomérulonéphrite extra-membraneuse ---
r_associated #0: 41 -->
en:mesangial matrix expansion
n1=glomérulonéphrite extra-membraneuse | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=41
- en:exercise-induced acute renal failure (in some patients) ---
r_associated #0: 40 -->
en:mesangial matrix expansion
n1=en:exercise-induced acute renal failure (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=40
- insuffisance rénale aigüe ---
r_associated #0: 40 -->
en:mesangial matrix expansion
n1=insuffisance rénale aigüe | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=40
- en:hemolytic-uremic syndrome requiring dialysis (1 patient) ---
r_associated #0: 39 -->
en:mesangial matrix expansion
n1=en:hemolytic-uremic syndrome requiring dialysis (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=39
- en:nephrogenic diabetes insipidus (less common) ---
r_associated #0: 39 -->
en:mesangial matrix expansion
n1=en:nephrogenic diabetes insipidus (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=39
- en:renal failure, slowly progressive ---
r_associated #0: 39 -->
en:mesangial matrix expansion
n1=en:renal failure, slowly progressive | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=39
- en:renal hypodysplasia ---
r_associated #0: 39 -->
en:mesangial matrix expansion
n1=en:renal hypodysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=39
- néphroblastomatose ---
r_associated #0: 39 -->
en:mesangial matrix expansion
n1=néphroblastomatose | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=39
- en:microcystic kidney ---
r_associated #0: 38 -->
en:mesangial matrix expansion
n1=en:microcystic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=38
- en:calcium oxalate/carbonate urolithiasis ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:calcium oxalate/carbonate urolithiasis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:congenital hypoplasia of kidney ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:congenital hypoplasia of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:defective urinary concentrating ability ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:defective urinary concentrating ability | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:kidney biopsy shows absence of differentiated proximal tubules ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:kidney biopsy shows absence of differentiated proximal tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:nephroblastomatosis ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:nephroblastomatosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:pelvicalyceal dilatation ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:pelvicalyceal dilatation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:tubulointerstitial atrophy ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=en:tubulointerstitial atrophy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- gros rein ---
r_associated #0: 37 -->
en:mesangial matrix expansion
n1=gros rein | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=37
- en:horseshoe kidney (rare) ---
r_associated #0: 36 -->
en:mesangial matrix expansion
n1=en:horseshoe kidney (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=36
- en:impaired renal function (variable) ---
r_associated #0: 36 -->
en:mesangial matrix expansion
n1=en:impaired renal function (variable) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=36
- en:kidney part ---
r_associated #0: 36 -->
en:mesangial matrix expansion
n1=en:kidney part | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=36
- en:perihilar mesangial deposition of proteinaceous material ---
r_associated #0: 36 -->
en:mesangial matrix expansion
n1=en:perihilar mesangial deposition of proteinaceous material | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=36
- en:echogenic kidneys ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:echogenic kidneys | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:elevated aldosterone secretion ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:elevated aldosterone secretion | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:end-stage renal disease (in some) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:end-stage renal disease (in some) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:enlarged mitochondria with paracrystalline inclusions ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:enlarged mitochondria with paracrystalline inclusions | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:glomerular basement membrane normal ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:glomerular basement membrane normal | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:hematuria ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:hematuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:impaired reabsorption of chloride ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:impaired reabsorption of chloride | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:increased urinary excretion of uric acid ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:increased urinary excretion of uric acid | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:kidney wilms tumor ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:kidney wilms tumor | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:medullary cystic renal disease ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:medullary cystic renal disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:microcystic change ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:microcystic change | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:mild subclinical decrease in renal function ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:mild subclinical decrease in renal function | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:multicystic kidney (rare, in males) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:multicystic kidney (rare, in males) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:no complement deposition ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:no complement deposition | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:pelvic dilation ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:pelvic dilation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:proteinuria (rare) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:proteinuria (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:pyelonephritis (in some patients) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:pyelonephritis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:renal agenesis, left-sided (1/4 patients) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:renal agenesis, left-sided (1/4 patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:renal anomalies (less common) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:renal anomalies (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:renal capsule ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:renal capsule | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:renal failure (most common cause of death) (iowa type 107680.0010) ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:renal failure (most common cause of death) (iowa type 107680.0010) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:renal scarring ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:renal scarring | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:some sclerotic glomeruli ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:some sclerotic glomeruli | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:uriniferous tubule ---
r_associated #0: 35 -->
en:mesangial matrix expansion
n1=en:uriniferous tubule | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=35
- en:abnormal glomeruli seen on biopsy ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:abnormal glomeruli seen on biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:absent kidneys (rare) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:absent kidneys (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:biopsy shows dilated proximal tubules ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:biopsy shows dilated proximal tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:diffuse mesangial sclerosis (less common) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:diffuse mesangial sclerosis (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:discrete dilatation of the right kidney pelvis (rare) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:discrete dilatation of the right kidney pelvis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:duplex renal system ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:duplex renal system | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:duplicated kidney (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:duplicated kidney (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:duplicated kidneys (rare) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:duplicated kidneys (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:end stage renal disease (33% of patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:end stage renal disease (33% of patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:end-stage renal failure (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:end-stage renal failure (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:enlarged kidney ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:enlarged kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:hypomagnesemia 2, renal ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:hypomagnesemia 2, renal | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:impaired renal absorption of cationic amino acids ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:impaired renal absorption of cationic amino acids | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:median onset of renal failure 19 years ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:median onset of renal failure 19 years | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:membranous glomerulonephritis ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:membranous glomerulonephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:microscopic hematuria ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:microscopic hematuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:mild proteinuria (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:mild proteinuria (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:nephrocalcinosis (rare) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:nephrocalcinosis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:proteinuria (in 2 of 3 siblings) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:proteinuria (in 2 of 3 siblings) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:proximal tubulopathy ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:proximal tubulopathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal agenesis/hypoplasia (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal agenesis/hypoplasia (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal biopsy showed interstitial fibrosis ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal biopsy showed interstitial fibrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal biopsy shows chronic interstitial nephritis ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal biopsy shows chronic interstitial nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal colic (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal colic (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal corticomedullary cysts ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal corticomedullary cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal cysts (1 patient) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal cysts (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal failure, mild ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal failure, mild | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal phosphate wasting (in some patients) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal phosphate wasting (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:renal tubular cell atrophy with corticomedullary cysts ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:renal tubular cell atrophy with corticomedullary cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:structure of inferior pole of kidney ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:structure of inferior pole of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:swelling of endothelial cells ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:swelling of endothelial cells | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- en:thickening of the glomerular basement membrane (later in the disease) ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=en:thickening of the glomerular basement membrane (later in the disease) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- tubule rénal ---
r_associated #0: 34 -->
en:mesangial matrix expansion
n1=tubule rénal | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=34
- hématurie macroscopique ---
r_associated #0: 33 -->
en:mesangial matrix expansion
n1=hématurie macroscopique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=33
- en:abnormal renal calyces ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:abnormal renal calyces | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:adrenal cortex atrophy (42%) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:adrenal cortex atrophy (42%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:anomalous renal pelvis (rare) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:anomalous renal pelvis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:chronic kidney disease ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:chronic kidney disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:chronic nephritis ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:chronic nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:dilated calyces (rare) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:dilated calyces (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:dilation of renal tubules, mild ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:dilation of renal tubules, mild | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:duplication of renal pelvis ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:duplication of renal pelvis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:dysplastic kidney (1 patient) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:dysplastic kidney (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:glomerulonephritis, autoimmune ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:glomerulonephritis, autoimmune | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:hydronephrosis (male) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:hydronephrosis (male) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:hypercalciuria ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:hypercalciuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:hypoplastic renal arteries (rare) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:hypoplastic renal arteries (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:immune complex nephritis ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:immune complex nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:increased renal salt reabsorption ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:increased renal salt reabsorption | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:interstitial inflammation ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:interstitial inflammation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:membranoproliferative glomerulonephritis (in about 26%) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:membranoproliferative glomerulonephritis (in about 26%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:nephrogenic rests (rare, in males) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:nephrogenic rests (rare, in males) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:nephronophthisis (rare) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:nephronophthisis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:normal kidneys ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:normal kidneys | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:polyuria (in some patients) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:polyuria (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:renal agenesis, unilateral (1 patient) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:renal agenesis, unilateral (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:renal cortical cysts ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:renal cortical cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:renal disease, uncharacterized (in some patients) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:renal disease, uncharacterized (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:renal juxtaglomerular cell hypertrophy/hyperplasia ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:renal juxtaglomerular cell hypertrophy/hyperplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:renal parenchymal disease ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:renal parenchymal disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:tabular atrophy ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:tabular atrophy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:tubulopathy (1 family) ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:tubulopathy (1 family) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:uric acid nephrolithiasis ---
r_associated #0: 32 -->
en:mesangial matrix expansion
n1=en:uric acid nephrolithiasis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=32
- en:chronic/endstage renal failure ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:chronic/endstage renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:cystic kidneys (rare) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:cystic kidneys (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:decreased kidney volume (1 patient) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:decreased kidney volume (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:dilated renal pelvis (rare) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:dilated renal pelvis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:hyperchromatic nuclei ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:hyperchromatic nuclei | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:hypoplastic/dysplastic kidney ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:hypoplastic/dysplastic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:increased echogenicity (1 of 2 patients) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:increased echogenicity (1 of 2 patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:increased glomerular cellularity ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:increased glomerular cellularity | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:nephronum ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:nephronum | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:patchy deposition of igg and igm ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:patchy deposition of igg and igm | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:podocyte effacement ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:podocyte effacement | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal abnormalities (in some patients) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal abnormalities (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal adysplasia ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal adysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal anomalies (in some) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal anomalies (in some) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal aplasia (less common) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal aplasia (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal cysts (in some patients) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal cysts (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal failure in adulthood ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal failure in adulthood | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal failure, endstage (in some patients) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal failure, endstage (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal hemangioblastoma ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal hemangioblastoma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:renal hypoplasia/aplasia ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:renal hypoplasia/aplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:segmental capillary wall thickening ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:segmental capillary wall thickening | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:tumors of the kidney (may progress to malignancy in less than 2%) ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=en:tumors of the kidney (may progress to malignancy in less than 2%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- glomérulite ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=glomérulite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- hypercalciurie ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=hypercalciurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- hématurie microscopique ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=hématurie microscopique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- néphrocalcinose ---
r_associated #0: 31 -->
en:mesangial matrix expansion
n1=néphrocalcinose | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=31
- en:abnormal corticomedullary differentiation ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:abnormal corticomedullary differentiation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:abnormal mitochondria in podocytes ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:abnormal mitochondria in podocytes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:absent renal function ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:absent renal function | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:adrenal hyperplasia ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:adrenal hyperplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:adult onset polycystic kidney (50%) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:adult onset polycystic kidney (50%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:atrophy of kidney ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:atrophy of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:cystic nephroma ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:cystic nephroma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:focal segmental glomerulosclerosis (less common) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:focal segmental glomerulosclerosis (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:glomerular and renal tubular cysts ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:glomerular and renal tubular cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:horseshoe kidney (1 patient) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:horseshoe kidney (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:hyperechogenic kidneys (in some patients) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:hyperechogenic kidneys (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:hypoaldosteronism, hyporeninemic ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:hypoaldosteronism, hyporeninemic | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:interstitial cell infiltrate ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:interstitial cell infiltrate | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:intralobular nephrogenic rests ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:intralobular nephrogenic rests | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:membranoproliferative glomerulonephritis (in some patients) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:membranoproliferative glomerulonephritis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:nephronophthisis ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:nephronophthisis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:polyuria (in some) ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:polyuria (in some) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:renal cell ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:renal cell | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:renal cortical microcysts ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:renal cortical microcysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:renal failure may occur with myoglobinuria ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:renal failure may occur with myoglobinuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:small echogenic kidneys ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:small echogenic kidneys | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:small medullary cysts ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:small medullary cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:swollen podocytes ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:swollen podocytes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:ultrasound shows hyperechoic kidneys ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:ultrasound shows hyperechoic kidneys | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:uromodulin reduced or absent in urine ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=en:uromodulin reduced or absent in urine | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- hypoaldostéronisme hyporéninémique ---
r_associated #0: 30 -->
en:mesangial matrix expansion
n1=hypoaldostéronisme hyporéninémique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=30
- en:adrenal hypoplasia ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:adrenal hypoplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:calcium oxalate urolithiasis ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:calcium oxalate urolithiasis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:calyceal dilation ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:calyceal dilation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:cystic kidneys (may be observed prenatally) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:cystic kidneys (may be observed prenatally) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:cystic tubular dilatation in the cortex and medulla ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:cystic tubular dilatation in the cortex and medulla | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:deposition of complement component c3 in glomerular basement membrane ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:deposition of complement component c3 in glomerular basement membrane | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:duplex kidney ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:duplex kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:end-stage renal disease (in some patients) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:end-stage renal disease (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:end-stage renal disease by third decade of life ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:end-stage renal disease by third decade of life | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:large nuclei (karyomegaly) in renal tubules seen renal biopsy ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:large nuclei (karyomegaly) in renal tubules seen renal biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:medullary cystic disease ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:medullary cystic disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:microcystic dysplasia ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:microcystic dysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:minimal change disease on renal biopsy ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:minimal change disease on renal biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:narrowing of the ureteropelvic junctions ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:narrowing of the ureteropelvic junctions | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:nephrocalcinosis ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:nephrocalcinosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:normal renal ultrasound at ages 4 and 7 ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:normal renal ultrasound at ages 4 and 7 | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:pelviureteric junction obstruction ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:pelviureteric junction obstruction | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:podocytes show microvillous transformation ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:podocytes show microvillous transformation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:progressive renal failure ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:progressive renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:recurrent urinary tract infection ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:recurrent urinary tract infection | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal anomalies (67% of patients) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal anomalies (67% of patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal biopsy shows glomerular sclerosis ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal biopsy shows glomerular sclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal biopsy shows tubular atrophy ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal biopsy shows tubular atrophy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal calculi (rare) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal calculi (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal cystic dysplasia (1 patient) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal cystic dysplasia (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal cysts (less common) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal cysts (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal disease (in some patients) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal disease (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal impairment ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal impairment | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal sodium wasting ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal sodium wasting | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:renal tubular degeneration ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:renal tubular degeneration | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:small kidney (reported in 1 patient) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:small kidney (reported in 1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:small kidneys (in some patients) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:small kidneys (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:structural abnormalities, mild ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:structural abnormalities, mild | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:structure of superior pole of kidney ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:structure of superior pole of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:thickening and disorganization of the glomerular basement membrane ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:thickening and disorganization of the glomerular basement membrane | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- en:tubular dilation (1 of 2 patients) ---
r_associated #0: 29 -->
en:mesangial matrix expansion
n1=en:tubular dilation (1 of 2 patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=29
- Anurie ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=Anurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:absent kidney ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:absent kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:anuria ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:anuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:biopsy shows decreased cytochrome c oxidase ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:biopsy shows decreased cytochrome c oxidase | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:cysts contain eosinophilic proteinaceous material ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:cysts contain eosinophilic proteinaceous material | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:dark urine following exercise ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:dark urine following exercise | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:double renal pelvis (in some patients) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:double renal pelvis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:electron microscopy shows foot-process effacement ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:electron microscopy shows foot-process effacement | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:entire kidney ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:entire kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:fanconi syndrome ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:fanconi syndrome | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:focal cystic changes ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:focal cystic changes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:focal segmental glomerulosclerosis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:focal segmental glomerulosclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:glomerulonephiitis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:glomerulonephiitis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:hydronephrosis (rare) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:hydronephrosis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:immature podocytes ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:immature podocytes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:impaired renal concentrating ability ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:impaired renal concentrating ability | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:kidney disorder ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:kidney disorder | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:low fractional excretion of uric acid ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:low fractional excretion of uric acid | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:malrotation of kidney ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:malrotation of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:membranoproliferative glomerulonephritis (26%) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:membranoproliferative glomerulonephritis (26%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:minimal change disease (lipoid nephrosis) on renal biopsy ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:minimal change disease (lipoid nephrosis) on renal biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:multicystic dysplastic kidney ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:multicystic dysplastic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:multicystic dysplastic kidneys (prenatal onset) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:multicystic dysplastic kidneys (prenatal onset) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:nephrotic syndrome (in some patients) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:nephrotic syndrome (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:no renal failure ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:no renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:normal distal tubule acid excretion ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:normal distal tubule acid excretion | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:pelvic kidney ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:pelvic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:reduced excretion of calcium ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:reduced excretion of calcium | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal amyloidosis, late-onset (uncommon) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal amyloidosis, late-onset (uncommon) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal biopsy shows diffuse mesangial sclerosis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal biopsy shows diffuse mesangial sclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal biopsy shows tubulointerstitial fibrosis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal biopsy shows tubulointerstitial fibrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal cell carcinoma (e.g., 193300.0002) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal cell carcinoma (e.g., 193300.0002) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal hypoplasia (less common) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal hypoplasia (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal medulla ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal medulla | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal mesangiolipidosis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal mesangiolipidosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal potassium wasting ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal potassium wasting | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:renal stones, bilateral ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:renal stones, bilateral | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:secondary renal insufficiency ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:secondary renal insufficiency | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:thickening of glomerular basement membrane ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:thickening of glomerular basement membrane | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:tubular cysts ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:tubular cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:unilateral renal agenesis ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:unilateral renal agenesis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:urinary tract dilatation (in some patients) ---
r_associated #0: 28 -->
en:mesangial matrix expansion
n1=en:urinary tract dilatation (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=28
- en:absence of renal corticomedullary differentiation ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:absence of renal corticomedullary differentiation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:adrenal hyperplasia, bilateral ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:adrenal hyperplasia, bilateral | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:altered basement membrane ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:altered basement membrane | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:aneurysm of renal artery ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:aneurysm of renal artery | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:bilateral hydronephrosis ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:bilateral hydronephrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:calcinosis of the renal parenchyma ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:calcinosis of the renal parenchyma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:calcium nephrolithiasis ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:calcium nephrolithiasis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:chronic renal dysfunction/failure ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:chronic renal dysfunction/failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:cystic kidney ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:cystic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:cystic kidney disease ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:cystic kidney disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:deposition of igg and complement seen on renal biopsy (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:deposition of igg and complement seen on renal biopsy (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:dilated cystic tubules ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:dilated cystic tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:ectopic kidney (2 patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:ectopic kidney (2 patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:glomerular filtration rate decreased ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:glomerular filtration rate decreased | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:glomerulus ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:glomerulus | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:hemolytic uremic syndrome (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:hemolytic uremic syndrome (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:histologically normal adrenal gland (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:histologically normal adrenal gland (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:hydronephrosis ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:hydronephrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:increased renal tubular phosphate reabsorption ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:increased renal tubular phosphate reabsorption | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:kidney transplantation ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:kidney transplantation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:mesangial proliferative glomerulonephritis (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:mesangial proliferative glomerulonephritis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:microcystic tubular dilatations ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:microcystic tubular dilatations | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:nephrocalcinosis is absent ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:nephrocalcinosis is absent | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:nephronophthisis-like nephropathy ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:nephronophthisis-like nephropathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:nephrotic syndrome (1 patient) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:nephrotic syndrome (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:no kidney disease ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:no kidney disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:oligomeganephronia ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:oligomeganephronia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:pigmenturia ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:pigmenturia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:proximal tubulopathy (1 patient) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:proximal tubulopathy (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal abnormalities ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal abnormalities | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal cortex calcification (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal cortex calcification (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal duplication (10%) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal duplication (10%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal dysplasia/aplasia ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal dysplasia/aplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal failure by age 3 ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal failure by age 3 | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal hamartoma ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal hamartoma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal stones (in one patient) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal stones (in one patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal stones (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal stones (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:renal tubular acidosis (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:renal tubular acidosis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:sclerosing glomerulonephropathy ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:sclerosing glomerulonephropathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- en:small echogenic kidneys (in some patients) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=en:small echogenic kidneys (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- hématurie ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=hématurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- insuffisance rénale (neuropathie et) ---
r_associated #0: 27 -->
en:mesangial matrix expansion
n1=insuffisance rénale (neuropathie et) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=27
- anurie ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=anurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:attenuation of the glomerular basement membrane ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:attenuation of the glomerular basement membrane | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:bicarbonate-wasting renal tubular acidosis ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:bicarbonate-wasting renal tubular acidosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:collapsing fsgs ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:collapsing fsgs | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:complement component deposition ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:complement component deposition | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:cystic changes in the kidney ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:cystic changes in the kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:decreased numbers of nephrons ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:decreased numbers of nephrons | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:decreased renal function ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:decreased renal function | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:dilated bowman capsules ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:dilated bowman capsules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:duplicated collecting system (1 patient) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:duplicated collecting system (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:dysplastic renal parenchyma ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:dysplastic renal parenchyma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:effacement of podocyte foot processes ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:effacement of podocyte foot processes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:focal glomerulosclerosis (in 33%) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:focal glomerulosclerosis (in 33%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:focal medullary hypoplasia ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:focal medullary hypoplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:focal tubular atrophy ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:focal tubular atrophy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:fused kidney ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:fused kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:global glomerulosclerosis ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:global glomerulosclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:glomerular c3 deposits, subendothelial and mesangial ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:glomerular c3 deposits, subendothelial and mesangial | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:glomerular dysfunction (variable) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:glomerular dysfunction (variable) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:glomerulocystic dysplasia ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:glomerulocystic dysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:glomerulonephropathy ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:glomerulonephropathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:hypoplastic glomerulocystic kidney disease ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:hypoplastic glomerulocystic kidney disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:kidney cyst ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:kidney cyst | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:lipid accumulation in kidney, especially in proximal convoluted tubules ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:lipid accumulation in kidney, especially in proximal convoluted tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:mesangial cell proliferation ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:mesangial cell proliferation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:nephritis, acute tubulointerstitial (mononuclear infiltrate) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:nephritis, acute tubulointerstitial (mononuclear infiltrate) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:nephrocalcinosis (in some patients) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:nephrocalcinosis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:nephrolithiasis (hcs and 2p21del) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:nephrolithiasis (hcs and 2p21del) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:nephronophthisis (1 patient) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:nephronophthisis (1 patient) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:nephronophthisis (less common) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:nephronophthisis (less common) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:polycystic kidney - body part ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:polycystic kidney - body part | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:proximal tubulopathy, generalized ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:proximal tubulopathy, generalized | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:pseudomembranous, calcified plaques in the renal collecting system (rare) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:pseudomembranous, calcified plaques in the renal collecting system (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:rare mesangial igm deposition ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:rare mesangial igm deposition | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:reduced renal function (in some patients with structural anomalies) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:reduced renal function (in some patients with structural anomalies) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:renal cortex ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:renal cortex | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:renal cysts (33%) ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:renal cysts (33%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:renal stone ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:renal stone | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:renal tubular acidosis ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:renal tubular acidosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:thickening of the glomerular basement membrane on renal biopsy ---
r_associated #0: 26 -->
en:mesangial matrix expansion
n1=en:thickening of the glomerular basement membrane on renal biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=26
- en:antibody deposits ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:antibody deposits | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:chronic interstitial nephritis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:chronic interstitial nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:congenital nephrotic syndrome - diffuse mesangial sclerosis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:congenital nephrotic syndrome - diffuse mesangial sclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:cystic renal dysplasia ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:cystic renal dysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:duplicated calyx ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:duplicated calyx | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:exercise-induced acute renal failure with acute tubular necrosis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:exercise-induced acute renal failure with acute tubular necrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:fetal pyelectasis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:fetal pyelectasis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:heterotopic kidney ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:heterotopic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:hyperuricemia ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:hyperuricemia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:hypoplastic kidneys (in some patients) ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:hypoplastic kidneys (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:inability to concentrate urine ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:inability to concentrate urine | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:ipsilateral renal agenesis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:ipsilateral renal agenesis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:medullary sponge kidney (rare) ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:medullary sponge kidney (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:proteinuria ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:proteinuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:renal anomalies (27%) ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:renal anomalies (27%) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:renal calcification (in some patients) ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:renal calcification (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:renal interstitial fibrosis ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:renal interstitial fibrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:transplanted kidney ---
r_associated #0: 25 -->
en:mesangial matrix expansion
n1=en:transplanted kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=25
- en:degenerative cysts ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:degenerative cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:early-onset end-stage renal disease ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:early-onset end-stage renal disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:ectopic kidney ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:ectopic kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:granular material in cortical tubules ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:granular material in cortical tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:hydronephrosis (in some patients) ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:hydronephrosis (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:hyperplasia of zona glomerulosa of adrenal gland ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:hyperplasia of zona glomerulosa of adrenal gland | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:kleds' disease ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:kleds' disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:nephronophthisis (1 of 2 patients) ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:nephronophthisis (1 of 2 patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:nephrosclerosis ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:nephrosclerosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:no nephritis ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:no nephritis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:polycystic kidney disease ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:polycystic kidney disease | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:proximal renal tubular acidosis ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:proximal renal tubular acidosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:renal dysplasia (wws) ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:renal dysplasia (wws) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- en:renal phosphate wasting ---
r_associated #0: 24 -->
en:mesangial matrix expansion
n1=en:renal phosphate wasting | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=24
- absence de la fonction rénale ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=absence de la fonction rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:abnormality of the renal collecting system ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:abnormality of the renal collecting system | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:acute nephritis (rare) ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:acute nephritis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:chronic kidney disease, stage 5 ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:chronic kidney disease, stage 5 | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:corticomedullary cysts ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:corticomedullary cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:deficient nephron differentiation ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:deficient nephron differentiation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:glomerulosclerosis and fibrosis ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:glomerulosclerosis and fibrosis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:hemoglobinuria (in some patients) ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:hemoglobinuria (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:hypertension, moderate ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:hypertension, moderate | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:interstitial nephropathy ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:interstitial nephropathy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:multiple renal cysts ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:multiple renal cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:reduced renal corticomedullary differentiation ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:reduced renal corticomedullary differentiation | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:renal malformation (in some patients) ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:renal malformation (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:renal malrotation (rare) ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:renal malrotation (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:renal pelvis ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:renal pelvis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:ureorrhea ---
r_associated #0: 23 -->
en:mesangial matrix expansion
n1=en:ureorrhea | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=23
- en:abnormal renal pelvises ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:abnormal renal pelvises | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:atrophic tubules ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:atrophic tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:basement membrane thickening ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:basement membrane thickening | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:bilateral renal hamartomas ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:bilateral renal hamartomas | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:cystic dysplasia ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:cystic dysplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:denuded tubules ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:denuded tubules | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:enlarged kidneys due to extramedullary hematopoiesis ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:enlarged kidneys due to extramedullary hematopoiesis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:foot process effacement ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:foot process effacement | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:glomerular crescents (rare), seen on biopsy ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:glomerular crescents (rare), seen on biopsy | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:hyperplasia ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:hyperplasia | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:increased echogenicity of entire parenchyma ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:increased echogenicity of entire parenchyma | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:isolated renal cyst (rare) ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:isolated renal cyst (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- en:nephrotic syndrome ---
r_associated #0: 22 -->
en:mesangial matrix expansion
n1=en:nephrotic syndrome | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=22
- défaillance respiratoire chronique ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=défaillance respiratoire chronique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:biopsy shows effacement of foot processes ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:biopsy shows effacement of foot processes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:calcification of renal arteries ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:calcification of renal arteries | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:chronic respiratory failure ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:chronic respiratory failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:congenital absence of kidney ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:congenital absence of kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:decreased tubular resorption of phosphate (in some patients) ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:decreased tubular resorption of phosphate (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:enlarged glomeruli ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:enlarged glomeruli | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:hydruria ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:hydruria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:hypotonic urine (in some patients) ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:hypotonic urine (in some patients) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:increased mesangial matrix ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:increased mesangial matrix | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:left kidney ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:left kidney | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:microvillus transformation of the podocytes ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:microvillus transformation of the podocytes | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:nephrolithiasis (rare) ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:nephrolithiasis (rare) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:no evidence of renal cysts ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:no evidence of renal cysts | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:renal aldosterone resistance ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:renal aldosterone resistance | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- en:renal insufficiency (in 2 of 3 siblings) ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=en:renal insufficiency (in 2 of 3 siblings) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- insuffisance respiratoire chronique ---
r_associated #0: 21 -->
en:mesangial matrix expansion
n1=insuffisance respiratoire chronique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=21
- Insuffisance rénale ---
r_associated #0: 15 -->
en:mesangial matrix expansion
n1=Insuffisance rénale | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=15
- glomerulo-néphrite ---
r_associated #0: 15 -->
en:mesangial matrix expansion
n1=glomerulo-néphrite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=15
- néphritique (syndrome) ---
r_associated #0: 15 -->
en:mesangial matrix expansion
n1=néphritique (syndrome) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=15
- néphropathies ---
r_associated #0: 11 -->
en:mesangial matrix expansion
n1=néphropathies | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=11
- troubles rénaux ---
r_associated #0: 11 -->
en:mesangial matrix expansion
n1=troubles rénaux | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=11
- Anton-Babinski (syndrome d') ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Anton-Babinski (syndrome d') | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Glomérulonéphrite ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Glomérulonéphrite | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Grönblad-Strandberg-Touraine (syndrome de) ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Grönblad-Strandberg-Touraine (syndrome de) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Insuffisance respiratoire chronique ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Insuffisance respiratoire chronique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Néphron ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Néphron | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Polyurie ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Polyurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Tübingen (périmètre de) ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=Tübingen (périmètre de) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- acidose rénale hyperchlorémique ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=acidose rénale hyperchlorémique | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:acute kidney failure ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:acute kidney failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:bloody urine ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:bloody urine | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:gross hematuria ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:gross hematuria | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:nephritic syndrom ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:nephritic syndrom | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:neuropathy and renal insufficiency ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:neuropathy and renal insufficiency | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:respiratory failure ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:respiratory failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- en:respiratory insufficiency ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=en:respiratory insufficiency | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- glomérulonéphropathie ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=glomérulonéphropathie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- hyperplasie ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=hyperplasie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- insuffisance d'adhérence leucocytaire (syndrome d') ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=insuffisance d'adhérence leucocytaire (syndrome d') | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- néphron sain (théorie du) ---
r_associated #0: 10 -->
en:mesangial matrix expansion
n1=néphron sain (théorie du) | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=10
- Hématurie ---
r_associated #0: 5 -->
en:mesangial matrix expansion
n1=Hématurie | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=5
- Tubule rénal ---
r_associated #0: 5 -->
en:mesangial matrix expansion
n1=Tubule rénal | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=5
- néphronophthise ---
r_associated #0: 5 -->
en:mesangial matrix expansion
n1=néphronophthise | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=5
|